Bernadette Connaughton, Director: Halozyme Therapeutics HALO Planned sale · Filed 05/01

Trade details

Type: Planned sale notice
Stock: Halozyme Therapeutics HALO
Person: Bernadette ConnaughtonDirector
Planned sale date: 26/05/01
Filed: 26/05/01

$310.3K to be sold

Halozyme Therapeutics trades, last 26 weeks

What else happened in Halozyme Therapeutics around then

Filed or reported within 30 days of the trade day · 04/01~05/31

Bernadette Connaughton's recent trades

Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$167.7K
1,626 sh
$167.7K
Filed 08/10
Traded 08/10
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$107.6K
1,625 sh
$107.6K
Filed 06/02
Traded 06/01
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$103.2K
1,625 sh
$103.2K
Filed 05/05
Traded 05/01
Bernadette ConnaughtonDirector
Sell10b5-1 planHalozyme Therapeutics
Sell10b5-1 plan
Halozyme Therapeutics
HALO
$140.5K
2,000 sh
$140.5K
Filed 01/06
Traded 01/05
Bernadette ConnaughtonDirector
Planned sale10b5-1 planHalozyme Therapeutics
Planned sale10b5-1 plan
Halozyme Therapeutics
HALO
$140.6K
2,000 sh
$140.6K
Filed 01/05
Traded 01/05